Irina Kenis

Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial

Hiddo J.L. Heerspink, Hans‐Henrik Parving, Dennis L. Andress et al. · The Lancet · 2019 · 612 citations · Full text

Medicine, Endocrinology, Nephrology +10

Dual endothelin antagonist aprocitentan for resistant hypertension (PRECISION): a multicentre, blinded, randomised, parallel-group, phase 3 trial

Markus P. Schlaich, M Bellet, Michael A. Weber et al. · The Lancet · 2022 · 227 citations · Full text

Medicine, Cardiology, Pharmacology +14

Simvastatin has deleterious effects on human first trimester placental explants

Irina Kenis, Shelly Tartakover‐Matalon, N. Cherepnin et al. · Human Reproduction · 2005 · 51 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

Impaired migration of trophoblast cells caused by simvastatin is associated with decreased membrane IGF-I receptor, MMP2 activity and HSP27 expression

Shelly Tartakover‐Matalon, N. Cherepnin, Marina Kuchuk et al. · Human Reproduction · 2006 · 20 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +16

Effects of Semaglutide With or Without Concomitant Mineralocorticoid Receptor Antagonist Use in Participants With Type 2 Diabetes and Chronic Kidney Disease: A FLOW Trial Prespecified Secondary Analysis

Peter Rossing, George L. Bakris, Vlado Perkovic et al. · Diabetes Care · 2025 · 10 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +15